| Issue | Title | |
| Vol 7, No 1 (2014) | EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE | Abstract PDF (Rus) |
| M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov | ||
| Vol 13, No 3 (2020) | Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making | Abstract PDF (Rus) |
| V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy | ||
| Vol 12, No 1 (2019) | Evaluation of the clinical efficacy of anti-asthma pharmacotherapy in children using the software package based on the Fishburn method | Abstract PDF (Rus) |
| O. V. Zhukova, I. V. Nikiforova | ||
| Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract PDF (Rus) |
| M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
| Vol 13, No 4 (2020) | Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system | Abstract PDF (Rus) |
| T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky | ||
| Vol 12, No 4 (2019) | Evolution of healthcare provider payment mechanisms | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina | ||
| Vol 15, No 2 (2022) | Experience of implementing a value-based approach in oncodermatology | Abstract PDF (Rus) |
| Yu. A. Zuenkova, D. I. Kicha, L. N. Izyurov | ||
| Vol 17, No 3 (2024) | Experience of using Beers criteria in clinical practice (according to Russian literature) | Abstract PDF (Rus) |
| M. S. Cherniaeva, M. A. Rozhkova, M. V. Kazakova, L. A. Egorova, O. M. Maslennikova, G. S. Lebedev, N. V. Lomakin, D. A. Sychev | ||
| Vol 14, No 4 (2021) | Experience of using telemedicine technologies in healthcare systems of foreign countries and the Russian Federation: systematic review | Abstract PDF (Rus) |
| O. A. Volkova, S. S. Budarin, E. V. Smirnova, Yu. V. Elbek | ||
| Vol 5, No 1 (2012) | EСOLOGO-ECONOMIC PROBLEMS OF TECHNOGENIC INFLUENCE OF POLLUTION ON DISEASE OF THE POPULATION | Abstract PDF (Rus) |
| A. I. Borodin, E. M. Ovchinnikov | ||
| Vol 9, No 4 (2016) | FACTORS AND EFFECTS OF PRIVATE HEALTH SPENDING | Abstract PDF (Rus) |
| O. A. Zarubina, N. N. Sisigina | ||
| Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract PDF (Rus) |
| D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
| Vol 11, No 4 (2018) | Financial statistical reporting by medical organizations: shortcomings and areas of optimization | Abstract PDF (Rus) |
| M. L. Lazareva, I. V. Tyurina | ||
| Vol 6, No 2 (2013) | FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS | Abstract PDF (Rus) |
| A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract PDF (Rus) |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| Vol 15, No 3 (2022) | Funding for coronavirus health worker payments | Abstract PDF (Rus) |
| I. Yu. Bocharova, A. Yu. Rymanov | ||
| Vol 9, No 2 (2016) | GENDER FEATURES OF THE POPULATION'S ATTITUDE TO MEDICINES | Abstract PDF (Rus) |
| N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
| Vol 8, No 3 (2015) | GOVERNMENTAL FUNDING OF BIOMEDICAL RESEARCH IN THE UNITED STATES OF AMERICA, GREAT BRITAIN AND GERMANY | Abstract PDF (Rus) |
| G. R. Khachatrtyan, O. Yu. Rebrova, V. V. Omelyanovskiy | ||
| Vol 9, No 3 (2016) | HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE | Abstract PDF (Rus) |
| A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 14, No 3 (2021) | Health economic evaluation of risdiplam in patients with spinal muscular atrophy | Abstract PDF (Rus) |
| А. S. Kolbin, А. А. Kurylev, Yu. Е. Balykina, М. А. Proskurin, S. А. Mishinova | ||
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract PDF (Rus) |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| Vol 13, No 1 (2020) | Health technology assessment in obstetrics: advantage of tailored conservative strategy vs surgical therapies of monochorionic twin complicated by TRAP-sequence | Abstract PDF (Rus) |
| V. I. Tsibizova, I. E. Govorov, I. I. Averkin, N. M. Khamani, D. V. Blinov | ||
| Vol 8, No 4 (2015) | HEALTHCARE SPENDING EFFICIENCY IN RUSSIAN REGIONS | Abstract PDF (Rus) |
| N. A. Avxentyev, V. M. Baydin, O. A. Zarubina, N. N. Sisigina, S. A. Kulkova | ||
| Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract PDF (Rus) |
| I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
| Vol 15, No 4 (2022) | Historical milestones of the invention and use of placebo | Abstract PDF (Rus) |
| A. N. Koterov | ||
| Vol 14, No 1 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources | Abstract PDF (Rus) |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| Vol 14, No 3 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization | Abstract PDF (Rus) |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| Vol 14, No 4 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals | Abstract PDF (Rus) |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| Vol 6, No 2 (2013) | HTA CORE MODEL | Abstract |
| R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov | ||
| Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract PDF (Rus) |
| E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
| Vol 11, No 2 (2018) | Implementation of the Federal Law «On Protection of Consumer Rights» in the provision of paid medical services: recommendations on signing the contract | Abstract PDF (Rus) |
| M. A. Amkhadova, E. V. Batler, D. G. Ilyuhin, I. A. Petrova | ||
| Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract PDF (Rus) |
| V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
| Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract PDF (Rus) |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| Vol 14, No 3 (2021) | Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases | Abstract PDF (Rus) |
| O. L. Zadvornaya, A. N. Pishchita | ||
| Vol 12, No 1 (2019) | Individual cost accounting in the management of medical organizations | Abstract PDF (Rus) |
| I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali | ||
| Vol 10, No 3 (2017) | Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis | Abstract PDF (Rus) |
| E. V. Biryukova, V. I. Ignat’eva | ||
| Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract PDF (Rus) |
| D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
| Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract PDF (Rus) |
| D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
| Vol 11, No 4 (2018) | International experience in determining the cost-effectiveness thresholds | Abstract PDF (Rus) |
| T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky | ||
| Vol 13, No 1 (2020) | Interregional research and practical conference with international attendance “Epilepsy and Paroxysmal Conditions as an Interdisciplinary Problem”(19 February 2020) | Abstract PDF (Rus) |
| D. A. Petrenko | ||
| Vol 11, No 2 (2018) | Introduction of medical products into healthcare practice and costs reimbursement: European experience | Abstract PDF (Rus) |
| V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii | ||
| Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Rus) PDF (Eng) |
| V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
| Vol 13, No 2 (2020) | Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? | Abstract PDF (Rus) |
| A. M. Lila, I. Yu. Torshin, O. A. Gromova | ||
| Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract PDF (Rus) |
| V. V. Omelyanovskiy | ||
| Vol 16, No 2 (2023) | Key principles of drug therapy in patients with chronic myeloid leukemia | Abstract PDF (Rus) |
| A. V. Zhuravlev, O. I. Knysh | ||
| Vol 16, No 4 (2023) | Legal particularities of AI technology usage in real-world data formation | Abstract PDF (Rus) |
| V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya | ||
| Vol 8, No 3 (2015) | LEGAL REGULATION OF STATE MANAGEMENT OF MEDICAL SCIENCE | Abstract PDF (Rus) |
| L. S. Melnikova, O. Yu. Rebrova, V. V. Omelyanovskiy | ||
| Vol 17, No 2 (2024) | Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology | Abstract PDF (Rus) |
| А. N. Rubashkina, I. Yu. Torshin, O. A. Gromova, A. N. Galustyan | ||
| 201 - 250 of 518 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
Popular articles
Vol 10, No 1 (2017)
Vol 17, No 3 (2024)
Vol 16, No 3 (2023)
Vol 16, No 4 (2023)
Vol 18, No 1 (2025)
Vol 13, No 1 (2020)
Keywords
COVID-19
NAFLD
budget impact
budget impact analysis
chemotherapy
children
chondroitin sulfate
clinical and economic analysis
cost minimization analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
drugs
evidence-based medicine
glucosamine sulfate
health technology assessment
pharmacoeconomic analysis
pharmacoeconomics
pharmacoepidemiology
pharmacoinformatics
quality of life
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
